Dermapharm Holding SE
XETRA:DMP

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
XETRA:DMP
Watchlist
Price: 37.8 EUR -0.53%
Market Cap: 2B EUR
Have any thoughts about
Dermapharm Holding SE?
Write Note

Dermapharm Holding SE
Investor Relations

In the bustling world of pharmaceuticals, Dermapharm Holding SE stands as a noteworthy player, crafting a narrative of strategic growth and innovation. Founded in 1991 and headquartered in Grünwald, Germany, Dermapharm presents itself as a vertically integrated pharmaceutical company whose operations stretch from development and production to marketing and distribution. This integration allows them to maintain control over their value chain, ensuring efficiency and quality across diverse product lines. Dermapharm's portfolio spans over 900 active pharmaceutical ingredients, health products, and medical devices, fortified through keenly orchestrated acquisitions that enhance their market presence and product offerings. Such strategic steps enable Dermapharm to leverage established brands while venturing into new sectors, reinforcing its reputation as a dynamic force in the pharmaceutical landscape.

Dermapharm primarily generates revenue by capitalizing on dermatological products, allergy treatments, systemic corticosteroids, and vitamin supplements. By addressing a broad spectrum of chronic and everyday health conditions, they serve both niche and mass-market demands across Europe. Dermapharm’s distinctive approach combines robust in-house research and development with targeted acquisitions, such as their acquisition of the Dr. Loges-Schuten pharmaceutical company, broadening their reach into phyto-pharmaceuticals and other sectors. Additionally, Dermapharm collaborates with partners to penetrate new geographical markets, thereby diversifying their revenue streams. Such initiatives underscore the company's agility and strategic foresight, ensuring sustained growth in a competitive industry.

Show more

Earnings Calls

No Earnings Calls Available

Management

Dr. Hans-Georg Feldmeier
CEO & Chairman of the Management Board
No Bio Available
Mr. Christof Dreibholz
CFO, Chief Compliance Officer & Member of Management Board
No Bio Available
Dr. Andreas Eberhorn
Chief Marketing Officer & Member of Management Board
No Bio Available
Ms. Britta Hamberger
Head of Investor Relations & Corporate Communications
No Bio Available

Contacts

Address
BAYERN
Gruenwald
Lil-Dagover-Ring 7
Contacts
+4989641860.0
ir.dermapharm.de